Xen Mendelsohn Aderka

InSightec Ltd. engages in the development of incisionless surgery through magnetic resonance-guided focused ultrasound technology. Its products include exablate neuro, exablate body system, and exablate prostate. It focuses on the treatment of tremors, Parkinson?s disease, uterine fibroids, bone metastases, and focal prostate cancer. The company was founded by Jackob Vortman and Tamir Oded on March 9, 1999 and is headquartered in Tirat Carmel, Israel.

InSightec Ltd. engages in the development of incisionless surgery through magnetic resonance-guided focused ultrasound technology. Its products include exablate neuro, exablate body system, and exablate prostate. It focuses on the treatment of tremors, Parkinson?s disease, uterine fibroids, bone metastases, and focal prostate cancer. The company was founded by Jackob Vortman and Tamir Oded on March 9, 1999 and is headquartered in Tirat Carmel, Israel.

InSightec Ltd. engages in the development of incisionless surgery through magnetic resonance-guided focused ultrasound technology. Its products include exablate neuro, exablate body system, and exablate prostate. It focuses on the treatment of tremors, Parkinson?s disease, uterine fibroids, bone metastases, and focal prostate cancer. The company was founded by Jackob Vortman and Tamir Oded on March 9, 1999 and is headquartered in Tirat Carmel, Israel.

InSightec Ltd. engages in the development of incisionless surgery through magnetic resonance-guided focused ultrasound technology. Its products include exablate neuro, exablate body system, and exablate prostate. It focuses on the treatment of tremors, Parkinson?s disease, uterine fibroids, bone metastases, and focal prostate cancer. The company was founded by Jackob Vortman and Tamir Oded on March 9, 1999 and is headquartered in Tirat Carmel, Israel.

InSightec Ltd. engages in the development of incisionless surgery through magnetic resonance-guided focused ultrasound technology. Its products include exablate neuro, exablate body system, and exablate prostate. It focuses on the treatment of tremors, Parkinson?s disease, uterine fibroids, bone metastases, and focal prostate cancer. The company was founded by Jackob Vortman and Tamir Oded on March 9, 1999 and is headquartered in Tirat Carmel, Israel.